title: Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial.
abstract: In therapeutic trials, it is crucial to identify Alzheimer's disease (AD) at its prodromal stage. We assessed the accuracy of the free and cued selective reminding test (FCSRT) compared to other cognitive tests to predict AD dementia in subjects with subjective cognitive decline or mild cognitive impairment. Subjects from the placebo group of the GuidAge trial over 70 years old and without clinical signs of dementia at baseline who completed the 5-year follow-up free of dementia (n = 840) or developed AD dementia (n = 73) were included in our study. Among all the tests, the sum of the 3 free recall of the FCSRT (FCSRT-FR) and the sum of free and cued recall (FCSRT-TR) yielded the best results to predict AD dementia occurrence (all p values <0.05 for comparison of FCSRT-FR ROC and MMSE, CDRsb, and CVF ROCs). FCSRT-FR had an area under the ROC curve of 0.799 (95% CI 0.738-0.85) and the optimal cut-off was 20 (se 68.06% , sp 81.43% , PPV 23.90% , NPV 96,75%). Concerning FCSRT-TR, the AUC was 0.776 and the optimal cut-off was 42 (se 62.5% , sp 82.26% , PPV 23.20% and NPV 96.24%). This study sets the framework for implementing the FCSRT in clinical and therapeutic trials for efficient subject selection.
authors.affiliation: AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
authors.forename: Francesca
authors.initials: F
authors.lastname: Di Stefano
authors.affiliation: AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.|ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, 47 Bd de l'Hôpital, Paris, France.
authors.forename: Stephane
authors.initials: S
authors.lastname: Epelbaum
authors.affiliation: INSERM U1027, Toulouse, France.|Faculté de Médecine Université Toulouse III, Toulouse, France.|Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France.
authors.forename: Nicola
authors.initials: N
authors.lastname: Coley
authors.affiliation: INSERM U1027, Toulouse, France.|Faculté de Médecine Université Toulouse III, Toulouse, France.|Department of Internal Medicine and Geriatrics, CHU Toulouse, Toulouse, France.
authors.forename: Christelle
authors.initials: C
authors.lastname: Cantet
authors.affiliation: INSERM U1027, Toulouse, France.|Faculté de Médecine Université Toulouse III, Toulouse, France.|Gérontopole, Toulouse University Hospital, Toulouse, France.
authors.forename: Pierre-Jean
authors.initials: PJ
authors.lastname: Ousset
authors.affiliation: AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.|ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, 47 Bd de l'Hôpital, Paris, France.|AXA Research Fund & UPMC Chair, Paris, France.
authors.forename: Harald
authors.initials: H
authors.lastname: Hampel
authors.affiliation: AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.|IHU-A-ICM - Paris Institute of Translational Neurosciences, Hôpital de la Pitié-Salpêtrière, Paris, France.
authors.forename: Hovagim
authors.initials: H
authors.lastname: Bakardjian
authors.affiliation: AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.|IHU-A-ICM - Paris Institute of Translational Neurosciences, Hôpital de la Pitié-Salpêtrière, Paris, France.|AXA Research Fund & UPMC Chair, Paris, France.
authors.forename: Simone
authors.initials: S
authors.lastname: Lista
authors.affiliation: INSERM U1027, Toulouse, France.|Faculté de Médecine Université Toulouse III, Toulouse, France.|Gérontopole, Toulouse University Hospital, Toulouse, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Vellas
authors.affiliation: AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Institut de la mémoire et de la maladie d'Alzheimer, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.|ICM, CNRS UMR 7225, Inserm U 1127, UPMC-P6 UMR S 1127, GH Pitié-Salpêtrière, 47 Bd de l'Hôpital, Paris, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Dubois
authors.affiliation: INSERM U1027, Toulouse, France.|Faculté de Médecine Université Toulouse III, Toulouse, France.|Gérontopole, Toulouse University Hospital, Toulouse, France.|Department of Epidemiology and Public Health, Toulouse University Hospital, Toulouse, France.
authors.forename: Sandrine
authors.initials: S
authors.lastname: Andrieu
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000517:prevention & control / Q000523:psychology*; D019540:Area Under Curve; D003072:Cognition Disorders / Q000175:diagnosis* / Q000469:parasitology* / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D011939:Mental Recall; D008609:Mental Status Schedule; D009483:Neuropsychological Tests; D010465:Perception; D062706:Prodromal Symptoms; D011379:Prognosis; D012372:ROC Curve
keywords: Alzheimer’s disease; IWG criteria; free and cued selective reminding test; prodromal; subjective cognitive decline